Trade AKBA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Akebia Therapeutics, Inc. (AKBA) is trading at US$0.92, up 2.26% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$251.22M. Over the past 52 weeks, AKBA has traded between US$0.81 and US$3.20. On Syfe you can trade AKBA with $0 commission and add it to your watchlist.
| Previous close | US$0.90 |
|---|---|
| Market cap | US$251.22M |
| 52-week range | US$0.81 – US$3.20 |
| Volume | 7.37M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vafseo. The company was founded by Joseph H. Gardner, John M. Rice Jr., Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Year: 2014
Akebia Therapeutics, US Renal Care Halt Kidney Disease Trial After Positive Interim Analysis
Jun 30, 12:57 PM · MT Newswires
Akebia Therapeutics Secures New Patent Covering Dosing Regimen for Chronic Kidney Disease
Jun 10, 12:55 PM · MT Newswires
Akebia Therapeutics Doses First Participants in Phase 1 Trial of AKB-9090 in Cardiac Surgery-Associated Acute Kidney Injury
Apr 13, 1:46 PM · MT Newswires
Akebia Therapeutics, Inc. (AKBA) stock is trading at US$0.92, +2.26% from the previous close of US$0.90.
The market cap for Akebia Therapeutics, Inc. (AKBA) stock is approximately US$251.22M.
The 52-week high for Akebia Therapeutics, Inc. (AKBA) stock is US$3.20.
The 52-week low for Akebia Therapeutics, Inc. (AKBA) stock is US$0.81.
Akebia Therapeutics, Inc. (AKBA) does not currently pay a dividend.
Stay on top of AKBA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
